Coverage dated October 23, 2026 to October 26, 2026

Diagnostic test could help doctors refine prostate cancer treatment

Headline from MedicalXpress

Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment …

MedicalXpress's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

3 articles, oldest first.

MedicalXpress
Diagnostic test could help doctors refine prostate cancer treatment (opens MedicalXpress)
Published Oct 23, 2026
MedicalXpress's feed description
Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment …
Cleveland Plain Dealer
Genomic test for prostate cancer: Could it change how doctors treat you? (opens Cleveland Plain Dealer)
Published Oct 26, 2026
Cleveland Plain Dealer's feed description
University Hospitals research suggests the Decipher tumor score could help doctors personalize treatment decisions for men with intermediate-risk prostate cancer.
Fox News
New test could flag which men need aggressive prostate cancer treatment and which don't (opens Fox News)
Published Oct 26, 2026
Fox News's feed description
The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy and which can skip it.